US 9163236
Pharmaceutical composition comprising NANOG SHRNA, and method of using NANOG SHRNA to treat cancer
granted A61PA61P35/00
Quick answer
US patent 9163236 (Pharmaceutical composition comprising NANOG SHRNA, and method of using NANOG SHRNA to treat cancer) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary, Dept. of Health and Human Services
- Grant date
- Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P35/00